Ibutilide Fumarate Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 0.1 mg /ml
Reference Brands: Corvert (USA)
Category:
Heart Disorder
Ibutilide Fumarate is available in Injection
and strengths such as 0.1 mg /ml.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ibutilide Fumarate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ibutilide Fumarate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ibutilide fumarate is a Class III antiarrhythmic agent indicated for the acute cardioconversion of atrial fibrillation and atrial flutter of recent onset to normal sinus rhythm. Marketed under the brand name Corvert, it is administered intravenously under strict medical supervision in a hospital setting.
Ibutilide exerts its antiarrhythmic effect by inducing a slow inward sodium current, which prolongs the action potential duration and refractory period of myocardial cells. This mechanism helps restore and maintain normal cardiac rhythm in patients experiencing recent-onset atrial arrhythmias. Due to its potent Class III antiarrhythmic activity, ibutilide must not be administered concomitantly with other Class Ia or Class III antiarrhythmic agents, as this may increase the risk of proarrhythmia.
Its intravenous formulation allows precise dosing and rapid therapeutic action, making it a critical intervention for acute management of atrial fibrillation and atrial flutter. Ibutilide fumarate remains an essential tool in cardiology for achieving timely rhythm control while monitoring for potential cardiac adverse events during treatment.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing